Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $16.85B.
ENTERPRISE VALUE (EV)
$16.85B
Medpace Holdings, Inc.
Market Cap
$17.21B
Enterprise Value (EV)
$16.85B
Market Cap
$13.17B
Enterprise Value (EV)
$16.01B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Medpace Holdings, Inc. (MEDP) | $17.21B | $16.85B |
| Revvity, Inc. (RVTY)vs › | $16.26B | $18.58B |
| Zimmer Biomet Holdings, Inc. (ZBH)vs › | $18.72B | $25.79B |
| Solventum Corporation (SOLV)vs › | $15.38B | $20.27B |
| Viatris Inc. (VTRS)vs › | $19.82B | $32.56B |
| Exelixis, Inc. (EXEL)vs › | $14.27B | $14.16B |
| STERIS plc (STE)vs › | $20.46B | $22.02B |
| United Therapeutics Corporation (UTHR)vs › | $21.16B | $19.36B |
| Charles River Laboratories International, Inc. (CRL)vs › | $13.17B | $16.01B |
| Penumbra, Inc. (PEN)vs › | $12.54B | $12.55B |
Market Cap
$17.21B
Total Debt
$136.85M
Cash
$497.05M
Enterprise Value
$16.85B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
